This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1
and if you wish to take away this text from our web site please contact us
Abstract
INTRODUCTION: Multimodal life-style interventions can delay or gradual Alzheimer’s illness (AD) in at-risk older adults, and plasma pTau217, a blood-based biomarker, now allows scalable AD threat stratification. Population-level screening integrating genetic, biomarker, and life-style threat components, alongside attitudes towards threat disclosure, stays understudied. This pilot assessed dementia-risk attitudes earlier than and after disclosure and examined a customized, data-driven multimodal teaching intervention in a high-risk Alabama inhabitants.
METHODS: Cognitively regular adults aged 65-75 with a first-degree relative affected by AD/dementia had been recruited in north Alabama and screened utilizing the Montreal Cognitive Assessment, household historical past, APOE genotyping, non-APOE AD polygenic threat rating, and plasma pTau217. A composite rubric categorized high-risk standing (rating >5 and/or pTau217 >0.18 pg/mL); high-risk members obtained outcomes disclosure and a 6-month customized intervention (dietitian-led teaching, cognitive coaching, exercise monitoring). Pre- and post-disclosure attitudes, misery (REVEAL IGT-AD scale), and biomarker/cognitive measures had been assessed.
RESULTS: Of 138 screened members, 52 (37.7%) had been high-risk, most (69.2%) by pTau217 alone. Before disclosure, subjective dementia-risk notion correlated with goal threat rating. Scores in keeping with post-disclosure clinically vital misery occurred in 28% of survey respondents in a minimum of one timepoint however was usually (50%) noticed with pre-existing nervousness/despair. Over 6 months, MoCA scores and life-style threat indices had been unchanged, pTau217 continued rising however at a slowed charge in comparison with between screening and the start of the life-style intervention, and self-reported fear and perceived dementia threat decreased considerably.
DISCUSSION: A genomics- and biomarker-informed screening and training mannequin is possible in a high-risk cohort within the deep south, with manageable misery and improved attitudes regardless of restricted short-term organic change. Findings assist bigger, longer, and extra various trials validating this method for AD screening.
Competing Interest Statement
The authors have declared no competing curiosity.
Clinical Trial
NCT07146412
Author Declarations
I affirm all related moral tips have been adopted, and any needed IRB and/or ethics committee approvals have been obtained.
Yes
The particulars of the IRB/oversight physique that supplied approval or exemption for the analysis described are given under:
WCG Institutional Review Board gave moral approval for this work (protocol #20250931).
I affirm that every one needed affected person/participant consent has been obtained and the suitable institutional types have been archived, and that any affected person/participant/pattern identifiers included weren’t recognized to anybody (e.g., hospital employees, sufferers or members themselves) exterior the analysis group so can’t be used to determine people.
Yes
I perceive that every one scientific trials and every other potential interventional research have to be registered with an ICMJE-approved registry, equivalent to ClinicalTrials.gov. I affirm that any such examine reported within the manuscript has been registered and the trial registration ID is supplied (notice: if posting a potential examine registered retrospectively, please present an announcement within the trial ID area explaining why the examine was not registered upfront).
Yes
I’ve adopted all applicable analysis reporting tips, equivalent to any related EQUATOR Network analysis reporting guidelines(s) and different pertinent materials, if relevant.
Yes
Data Availability
All information produced within the current examine can be found upon affordable request to the authors.
This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1
and if you wish to take away this text from our web site please contact us

